XM Therapeutics
PrivateLast Round
Seed
Oct 10, 2023
Total Funding Raised
$375,000
Company Overview
XM Therapeutics operates in Healthcare & Life Sciences and is based in Providence, Rhode Island. Its latest recorded funding round was a Seed round in October 2023.
XM Therapeutics is a biotechnology company developing novel therapies based on injectable extracellular matrix particles to repair and modulate diseased tissue for treating chronic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XM Therapeutics Comparables
Compare XM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ECM Therapeutics, Inc. | 81% | |
| Ventrix Bio | 77% | |
| TissueForm, Inc. | 67% |
For institutional investors. Book with your work email.
XM Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
XM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevity Investor Network | Seed |
| Slater Technology Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2023
$375K round led by Slater Technology Fund
For institutional investors. Book with your work email.
XM Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about XM Therapeutics's valuation, stock price, and market status.
Is XM Therapeutics a public or private company?
XM Therapeutics is a private company.
What is the current stock price of XM Therapeutics?
XM Therapeutics is a private company, so its shares have no public market price. Caplight tracks XM Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is XM Therapeutics worth (valuation)?
Valuation information for XM Therapeutics is not publicly available.
Can I buy XM Therapeutics stock?
XM Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was XM Therapeutics's last funding round?
XM Therapeutics's most recent funding round was Seed on October 10, 2023.
Who are the main investors in XM Therapeutics?
Key investors in XM Therapeutics include Slater Technology Fund.
Will XM Therapeutics IPO soon?
No public IPO plans have been announced for XM Therapeutics.
How can I track XM Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in XM Therapeutics's shares on secondary markets.